DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
AD1112417
Title:
Investigating Novel Approaches to Block Inflammation and Prevent Ischemia Reperfusion Injury During VCA Transplantation
Report Date:
2020-05-01
Abstract:
Ischemia reperfusion injury (IRI) contributes to inflammation, acute rejection, and negatively impacts VCA function and survival. Strategies to prevent IRI could decrease rejection episodes, improve VCA outcomes and facilitate immune tolerance induction strategies. Galectin-3 (Gal3), a beta-galactoside binding lectin, contributes to acute inflammation in response to tissue hypoxia, an unavoidable consequence of organ harvest and VCA transplantation. Blocking extracellular Gal3 using known Gal3 inhibitors including modified citrus pectin (MCP) has been shown in animal models to reduce inflammation and fibrosis. This proposal will elucidate the role of Gal3 in VCA IRI. We hypothesize that Gal3 significantly contributes to VCA IRI and that blocking extracellular Gal3 function using MCP can serve as a novel therapeutic approach to prevent or reduce IRI. We also hypothesize that circulating Gal3 levels can serve as a predictive biomarker of IRI and VCA function post transplantation.
Document Type:
Conference:
Journal:
Pages:
14
File Size:
0.45MB
W81XWH-19-1-0163
(W81XWH1910163);
Contracts:
Grants:
Distribution Statement:
Approved For Public Release
